Volitionrx (VNRX) Depreciation and Depletion (2015 - 2025)
Volitionrx (VNRX) posted Depreciation and Depletion of $264982.0 for Q4 2025, up 9.45% on a QoQ basis from $242093.0 in Q3 2025, and down 6.75% year-over-year from $284176.0 in Q4 2024.
Volitionrx (VNRX) Depreciation and Depletion (2015 - 2025) Analysis & Trends
Volitionrx's Depreciation and Depletion history runs 11 years deep, the most recent figure standing at $264982.0 for Q4 2025.
- Quarterly Depreciation and Depletion fell 6.75% year-over-year to $264982.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 million (down 9.09% YoY) and the FY2025 annual result came in at $1.0 million, down 9.09% from the prior year.
- Depreciation and Depletion was $264982.0 for Q4 2025 at Volitionrx, up from $242093.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $307768.0 in Q4 2023 and bottomed at $173018.0 in Q4 2021.
- A 5-year average of $243868.6 and a median of $246462.5 in 2025 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2021 — Depreciation and Depletion jumped 49.54% — and 2025, when it dropped 11.26%.
- Volitionrx's Depreciation and Depletion stood at $173018.0 in 2021, then jumped by 38.96% to $240432.0 in 2022, then grew by 28.01% to $307768.0 in 2023, then decreased by 7.67% to $284176.0 in 2024, then dropped by 6.75% to $264982.0 in 2025.
- Business Quant data shows VNRX's Depreciation and Depletion at $264982.0 in Q4 2025, $242093.0 in Q3 2025, and $246677.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 308.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 89.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Volitionrx | 109,643.10 | -2.35 Mn | - | 264,982.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 264,982.00 |
| Dec 31, 2025 | 264,982.00 |
| Sep 30, 2025 | 242,093.00 |
| Sep 30, 2025 | 242,093.00 |
| Jun 30, 2025 | 246,677.00 |
| Jun 30, 2025 | 246,677.00 |
| Mar 31, 2025 | 246,248.00 |
| Mar 31, 2025 | 246,248.00 |
| Dec 31, 2024 | 284,176.00 |
| Dec 31, 2024 | 284,176.00 |
| Sep 30, 2024 | 270,696.00 |
| Sep 30, 2024 | 270,696.00 |
| Jun 30, 2024 | 267,627.00 |
| Jun 30, 2024 | 267,627.00 |
| Mar 31, 2024 | 277,501.00 |
| Mar 31, 2024 | 277,501.00 |
| Dec 31, 2023 | 307,768.00 |
| Dec 31, 2023 | 307,768.00 |
| Sep 30, 2023 | 274,311.00 |
| Sep 30, 2023 | 274,311.00 |